Effects of solvents and penetration enhancers on transdermal delivery of thymoquinone: permeability and skin deposition study

References

• Akhondzadeh S, Abbasi SH. (2006). Herbal medicine in the treatment of Alzheimer's disease. Am J Alzheimers Dis Other Demen 21:113–8.
   PubMedGoogle Scholar
• Alhebshi A, Gotoh M, Suzuki I. (2013). Thymoquinone protects cultured rat primary neurons against amyloid β-induced neurotoxicity. Biochem Biophys Res Commun 433:362–7.
   PubMed Web of Science ®Google Scholar
• Ameen D, Michniak-Kohn B. (2017). Transdermal delivery of dimethyl fumarate for Alzheimer's disease: effect of penetration enhancers. Int J Pharm 529:465–73.
   PubMed Web of Science ®Google Scholar
• Atef E, Altuwaijri N. (2018). Using Raman spectroscopy in studying the effect of propylene glycol, oleic acid, and their combination on the rat skin. AAPS PharmSciTech 19:114–22.
   PubMed Web of Science ®Google Scholar
• Aungst BJ, J. Rogers N, Shefter E. (1986). Enhancement of naloxone penetration through human skin in vitro using fatty acids, fatty alcohols, surfactants, sulfoxides and amides. Int J Pharm 33:225–34.
   Web of Science ®Google Scholar
• Barry BW. (2001). Novel mechanisms and devices to enable successful transdermal drug delivery. Eur J Pharm Sci 14:101–14.
   PubMed Web of Science ®Google Scholar
• Bendas B, Schmalfuβ U, Neubert R. (1995). Influence of propylene glycol as cosolvent on mechanisms of drug transport from hydrogels. Int J Pharm 116:19–30.
   Web of Science ®Google Scholar
• Bennett SL, Barry BW. (1985). Effectiveness of skin penetration enhancers propylene glycol, azone, decylmethylsulphoxide and oleic acid with model polar (mannitol) and nonpolar (hydrocortisone) penetrants. J Pharm Pharmacol 37:84P.
   PubMed Web of Science ®Google Scholar
• Bommannan D, Potts RO, Guy RH. (1991). Examination of the effect of ethanol on human stratum corneum in vivo using infrared spectroscopy. J Control Release 16:299–304.
   Web of Science ®Google Scholar
• Deepak SS, Sikender M, Garg V, Samim M. (2011). Entrapment of seed extract of Nigella sativa into thermosensitive (NIPAAm–Co–VP) co-polymeric micelles and its antibacterial activity. Int J Pharm Sci Drug Res 3:246–52.
   Google Scholar
• Elias PM. (2012). Structure and function of the stratum corneum extracellular matrix. J Invest Dermatol 132:2131–33.
   PubMed Web of Science ®Google Scholar
• Gali-Muhtasib H, Roessner A, Schneider-Stock R. (2006). Thymoquinone: a promising anti-cancer drug from natural sources. Int J Biochem Cell Biol 38:1249–53.
   PubMed Web of Science ®Google Scholar
• Haq A, Goodyear B, Ameen D, et al. (2018). Strat-M(R) synthetic membrane: permeability comparison to human cadaver skin. Int J Pharm 547:432–37.
   PubMed Web of Science ®Google Scholar
• Jung E, Kang YP, Yoon I-S, et al. (2013). Effect of permeation enhancers on transdermal delivery of fluoxetine: in vitro and in vivo evaluation. Int J Pharm 456:362–69.
   PubMed Web of Science ®Google Scholar
• Krishnaiah YS, Satyanarayana V, Karthikeyan RS. (2002). Effect of the solvent system on the in vitro permeability of nicardipine hydrochloride through excised rat epidermis. J Pharm Pharm Sci 5:123–30.
   PubMed Web of Science ®Google Scholar
• Kurihara-Bergstrom T, Knutson K, Denoble LJ, Goates CY. (1990). Percutaneous absorption enhancement of an ionic molecule by ethanol–water systems in human skin. Pharm Res 7:762–66.
   PubMed Web of Science ®Google Scholar
• Lane ME. (2013). Skin penetration enhancers. Int J Pharm 447:12–21.
   PubMed Web of Science ®Google Scholar
• Levang AK, Zhao K, Singh J. (1999). Effect of ethanol/propylene glycol on the in vitro percutaneous absorption of aspirin, biophysical changes and macroscopic barrier properties of the skin. Int J Pharm 181:255–63.
   PubMed Web of Science ®Google Scholar
• Marwah H, Garg T, Goyal AK, Rath G. (2016). Permeation enhancer strategies in transdermal drug delivery. Drug Deliv 23:564–78.
   PubMed Web of Science ®Google Scholar
• Mitragotri S, Anissimov YG, Bunge AL, et al. (2011). Mathematical models of skin permeability: an overview. Int J Pharm 418:115–29.
   PubMed Web of Science ®Google Scholar
• Nair HB, Sung B, Yadav VR, et al. (2010). Delivery of antiinflammatory nutraceuticals by nanoparticles for the prevention and treatment of cancer. Biochem Pharmacol 80:1833–43.
   PubMed Web of Science ®Google Scholar
• Pathan IB, Setty CM. (2009). Chemical penetration enhancers for transdermal drug delivery systems. Trop J Pharm Res 8:173–9.
   Web of Science ®Google Scholar
• Rao Y, Zheng F, Liang X, et al. (2015). Penetration profile and human cadaver skin distribution of finasteride from vesicular nanocarriers. Drug Deliv 22:1003–9.
   PubMed Web of Science ®Google Scholar
• Salmani JMM, Asghar S, Lv H, Zhou J. (2014). Aqueous solubility and degradation kinetics of the phytochemical anticancer thymoquinone; probing the effects of solvents, pH and light. Molecules 19:5925–39.
   PubMed Web of Science ®Google Scholar
• Samad A, Ullah Z, Alam MI, et al. (2009). Transdermal drug delivery system: patent reviews. Recent Pat Drug Deliv Formul 3:143–52.
   PubMedGoogle Scholar
• Schneider-Stock R, Fakhoury IH, Zaki AM, et al. (2014). Thymoquinone: fifty years of success in the battle against cancer models. Drug Discov Today 19:18–30.
   PubMed Web of Science ®Google Scholar
• Shah PP, Desai PR, Patel AR, Singh MS. (2012). Skin permeating nanogel for the cutaneous co-delivery of two anti-inflammatory drugs. Biomaterials 33:1607–17.
   PubMed Web of Science ®Google Scholar
• Singh A, Ahmad I, Akhter S, et al. (2012a). Thymoquinone: major molecular targets, prominent pharmacological actions and drug delivery concerns. Curr Bioactive Compounds 8:334–44.
   Google Scholar
• Singh K, Arora N, Garg T. (2012b). Superbug: antimicrobial resistance due to NDM-1. Int J Inst Pharm Life Sci 2:58–66.
   Google Scholar
• Sloan KB, Koch SA, Siver KG, Flowers FP. (1986). Use of solubility parameters of drug and vehicle to predict flux through skin. J Invest Dermatol 87:244–52.
   PubMed Web of Science ®Google Scholar
• Stoughton RR, Mcclure WO. (1983). Azone®: a new non-toxic enhancer of cu'taneous penetration. Drug Dev Ind Pharm 9:725–44.
   Web of Science ®Google Scholar
• Tiwary AK, Sapra B, Jain S. (2007). Innovations in transdermal drug delivery: formulations and techniques. Recent Pat Drug Deliv Formul 1:23–36.
   PubMedGoogle Scholar
• Vavrova K, Zbytovska J, Hrabalek A. (2005). Amphiphilic transdermal permeation enhancers: structure-activity relationships. Curr Med Chem 12:2273–91.
   PubMed Web of Science ®Google Scholar
• Williams AC, Barry BW. (2012). Penetration enhancers. Adv Drug Deliv Rev 64:128–37.
   Web of Science ®Google Scholar